Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of snail

Journal of Bone and Mineral Research

Volumn 25, Issue 4, 2010, Pages 830-840

  Bai, Shaochun ^a   Wang, Hongwei ^a   Shen, Jikun ^a   Zhou, Randal ^a   Bushinsky, David A ^b   Favus, Murray J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

GHS rats; Hypercalciuria; Intestine; Kidney; Snail; Vitamin D receptor

Indexed keywords

HISTONE H3; TRANSCRIPTION FACTOR SNAIL; VITAMIN D RECEPTOR;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; E BOX ELEMENT; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERCALCIURIA; INTESTINE CELL; KIDNEY CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; STONE FORMATION;

ACETYLATION; ANIMALS; CELL LINE; COLON; DOWN-REGULATION; E-BOX ELEMENTS; FEMALE; GENE EXPRESSION; HISTONES; HUMANS; HYPERCALCIURIA; INTESTINES; KIDNEY CALCULI; MALE; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTORS;

EID: 77953449738     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091010     Document Type: Article

References (51)

1. Coe FLF, Favus MJ, Asplin JR. Nephrolithiasis. In: The Kidney, 7th ed. Philadelphia: Saunders; 2004:1819-1866.
2. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51:894-900. (Pubitemid 27157979)
3. Pak CY, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69:19-30. (Pubitemid 10084682)
4. Liberman UA, Barzel U, De Vries A, Ellis H. Myositis ossificans traumatica with unusual course: effect of EDTA on calcium, phosphorus and manganese excretion. Am J Med Sci. 1967;254:35-47.
5. Birge SJ, Peck WA, Berman M, Whedon GD. Study of calcium absorption in man: a kinetic analysis and physiologic model. J Clin Invest. 1969;48:1705-1713.
6. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CY. The role of 1α,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest. 1977;59:756-760.
7. Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med. 1977;90:955-962.
8. Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med. 1984;311:73-80. (Pubitemid 14084077)
9. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol. 1984;247:F1-F13.
10. Asplin JR, Donahue S, Kinder J, Coe FL. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006;70:1463-1467. (Pubitemid 44527316)
11. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300:337-340.
12. Stechman MJ, Loh NY, Thakker RV. Genetics of hypercalciuric nephrolithiasis: renal stone disease. Ann N Y Acad Sci. 2007;1116:461-484. (Pubitemid 350274327)
13. Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol. 2005;16:729-745.
14. Bushinsky DA. Genetic hypercalciuric stone forming rats. Semin Nephrol. 1996;16:448-457.
15. Bushinsky DA, Favus MJ. Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport. J Clin Invest. 1988;82:1585-1591.
16. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int. 1993;43:189-196. (Pubitemid 23167465)
17. 3 in bone from genetic hypercalciuric rats. Am J Physiol. 1996;271: (1 Pt 1):C130-135.
18. Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int. 1997;51:1540-1547. (Pubitemid 27239910)
19. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999;55:602-612. (Pubitemid 29082886)
20. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest. 1993;91:661-667. (Pubitemid 23064152)
21. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994;45:58-65. (Pubitemid 24045992)
22. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995;48:1705-1713.
23. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2000;57:550-560.
24. Bushinsky DA, Grynpas MD, Asplin JR. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2001;59:1415-1423.
25. Bushinsky DA, Asplin JR, Grynpas MD, et al. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002;61:975-987.
26. Adams ND, Gray RW, Lemann J Jr, Cheung HS. Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int. 1982; 21:90-97.
27. 2-vitamin D concentrations in healthy men. Kidney Int. 1983;24:555-560.
28. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982;72:25-32.
29. Insogna KL, Broadus AE, Dreyer BE, Ellison AF, Gertner JM. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab. 1985;61:490-495.
30. Pak CY, Oata M, Lawrence EC, Snyder W. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest. 1974;54:387-400.
31. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, et al. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res. 2005;20:447-454.
32. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004;89:4937-4943.
33. Canaff L, Hendy GN. Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002;277:30337-30350.
34. 3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol. 2005;16:1300-1308.
35. Bai S, Favus MJ. Vitamin D and calcium receptors: links to hypercalciuria. Curr Opin Nephrol Hypertens. 2006;15:381-385.
36. Bai S, Bushinsky DA, Favus MJ. Increased vitamin D receptor gene expression in genetic hypercalciuric rats is accompanied by downregulation of Snail. J Bone Miner Res. 2006;21:S616.
37. Palmer HG, Larriba MJ, Garcia JM, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;10:917-919.
38. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005;132:3151-3161. (Pubitemid 41167144)
39. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76-83.
40. Larriba MJ, Munoz A. SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer. 2005;92:985-989. (Pubitemid 40546657)
41. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol. 2001;21:8184-8188. (Pubitemid 33051806)
42. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128:707-719.
43. Li B, Ruan C, Workman JL. Histones: should I stay or should I go? Genome Biol. 2005;6:306.
44. 3 in mouse kidney and intestine in vivo. J Biol Chem. 2007;282:22344-22352.
45. Zheng W, Xie Y, Li G, Kong J, Feng JQ, Li YC. Critical role of calbindin-D28k in calcium homeostasis revealed by mice lacking both vitamin D receptor and calbindin-D28k. J Biol Chem. 2004;279:52406-52413. (Pubitemid 39656617)
46. Okano T, Tsugawa N, Morishita A, Kato S. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha. 25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2004;89-90:335-338. (Pubitemid 38844306)
47. 3: a new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest. 1998;101:2223-2232.
48. 3. Mol Endocrinol. 2006;20:1231-1247.
49. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84-89.
50. Kataoka H, Murayama T, Yokode M, et al. A novel snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs. Nucleic Acids Res. 2000;28:626-633.
51. Pena C, Garcia JM, Silva J, et al. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet. 2005;14:3361-3370.